Gastrointestinal Cancer Update

By: Dr Neil Love
Listen for free

  • Summary

  • This series bridges the gap between research and patient care by providing medical oncologists and hematologists with ongoing access to the perspectives and opinions of national and international clinical investigators with expertise in gastrointestinal cancers.
    Copyright 2008 Research To Practice. All Rights Reserved
    Show More Show Less
Science
Show More Show Less
activate_samplebutton_t1
Episodes
  • Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers

    Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers
    Sep 20 2024
    Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, summarize the treatment landscape for patients with biliary tract cancers and review recent advancements in the field.
    Show More Show Less
    2 hrs and 15 mins
  • Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors

    Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
    Sep 19 2024
    Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.
    Show More Show Less
    59 mins
  • Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

    Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
    Sep 13 2024
    Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers.
    Show More Show Less
    1 hr and 1 min

What listeners say about Gastrointestinal Cancer Update

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available